Latest Breaking News On - Amicus therapeutics inc - Page 1 : vimarsana.com

Hillsdale Investment Management Inc Acquires 23,640 Shares of Amicus Therapeutics, Inc (NASDAQ:FOLD)

Hillsdale Investment Management Inc. lifted its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 8.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 294,300 shares of the biopharmaceutical company’s stock after purchasing an additional 23,640 shares during the period. Hillsdale […]

United statesMargaretg mcglynnE fund management coProfund advisorsFund management coAmicus therapeutics incJpmorgan chase coHillsdale investment management incAmicus therapeutics company profileAssociates corpMorgan stanleyNeedham companyAmicus therapeuticsHillsdale investment managementFree reportInvestment management

Guggenheim Upgrades Amicus Therapeutics (NASDAQ:FOLD) to Buy

Guggenheim Upgrades Amicus Therapeutics (NASDAQ:FOLD) to Buy
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankBradleyl campbellJohnf crowleyAmicus therapeutics company profileCantor fitzgeraldYork mellon corpMorgan stanleyChina universal asset management coNeedham companyAmicus therapeutics incAmicus therapeuticsAssetmark incFree reportModerate buyGet free report

Lysosomal Storage Disease Treatment Market To Receive Overwhelming Hike In Revenues By 2027

Lysosomal Storage Disease Treatment Market To Receive Overwhelming Hike In Revenues By 2027
briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.

Eli lillyYogesh singhProtalix biotherapeutics incRaptor pharmaceutical corpActelion pharmaceuticals ltdSanofi genzyme corporationResearch organizationsPfizer incBiomarin pharmaceutical incAmicus therapeutics incMerck co incStorage disease treatment marketDisease typeBatten diseaseFabry diseaseEnzyme replacement therapy

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Up to $9 04

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Up to $9 04
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesBradleyl campbellMargaretg mcglynnComerica bankCantor fitzgeraldAmicus therapeuticsAmicus therapeutics incAmerican international group incMorgan stanleyFranklin resources incAssociates corpGet free reportDirector margaretState retirement systemAmerican international groupInternational group

Morgan Stanley Lowers Amicus Therapeutics (NASDAQ:FOLD) Price Target to $19 00

Morgan Stanley Lowers Amicus Therapeutics (NASDAQ:FOLD) Price Target to $19 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesJohnf crowleyBradleyl campbellAmicus therapeuticsEnvestnet asset management incAmicus therapeutics incCantor fitzgeraldVanguard group incMorgan stanleyVontobel holding ltdJpmorgan chase coNeedham companyAmicus therapeutics company profileSecurities exchange commissionShaughnessy asset managementGet free report